Concepedia

Jaskaran Singh

JS

Statistics

Publications

60

Citations

12.3K

H-Index

33

Active since

2004

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

Yale University

Neurocrine Biosciences (United States)

Janssen Scientific Affairs (United States)

Jaskaran Singh is an author at Janssen (United States) specializing in psychopharmacology, antidepressant therapy, and antidepressant pharmacotherapy.

ORCID

Publications per year

2004–2025

60

Publications

60

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

Carlos A. Zarate, Jaskaran Singh, Paul J. Carlson et al. · Archives of General Psychiatry · 2006 · 3.8K citations · Full text

, , +17

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

Vanina Popova, Ella Daly, Madhukar H. Trivedi et al. · American Journal of Psychiatry · 2019 · 872 citations · Full text

, , +17

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

Ella Daly, Madhukar H. Trivedi, Adam Janik et al. · JAMA Psychiatry · 2019 · 759 citations · Full text

, , +17

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

Ella Daly, Jaskaran Singh, Maggie Fedgchin et al. · JAMA Psychiatry · 2017 · 705 citations · Full text

, , +16

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin et al. · American Journal of Psychiatry · 2018 · 665 citations · Full text

, , +17

1–5 of 60